Helminthic therapy and multiple sclerosis (MS)
The scientific evidence[edit | edit source]
- 2025 Apr 22 Modulation of the Inflammatory Signature in an Experimental Autoimmune Encephalomyelitis Model through Treatment with Fasciola hepatica-Derived Recombinant Fatty Acid Binding Protein (rFh15) -- Full text
- 2025 Feb 28 An immunoregulatory amphipathic peptide derived from Fasciola hepatica helminth defense molecule (FhHDM-1.C2) exhibits potent biotherapeutic activity in a murine model of multiple sclerosis -- Full text | PDF
- 2024 Oct 30 Helminth infection and Multiple Sclerosis
- 2024 Jan 15 Modulatory Effects of Hydatid Cyst Fluid on a Mouse Model of Experimental Autoimmune Encephalomyelitis -- Full text | PDF
- 2024 Effect of infections on multiple sclerosis (chapter of Mechanisms of Disease Pathogenesis in Multiple Sclerosis)
- 2023 Jan 23 Nematode-Induced Growth Factors Related to Angiogenesis in Autoimmune Disease Attenuation -- Full text | PDF
- 2022 Jun 13 Multiple sclerosis and the microbiota: Progress in understanding the contribution of the gut microbiome to disease -- Full text | PDF.
- A narrative review of the literature on MS and the microbiota included consideration of how the re-introduction of complex eukaryotic symbionts, especially helminths and protists, halts the progression of RRMS by direct modulation of the host immune system, providing conclusive evidence to support the idea that the loss of eukaryotic symbionts is the pivotal evolutionary mismatch that underlies the pathogenesis and progression of MS.
- 2021 Nov Interleukin-35 is a critical regulator of immunity during helminth infections associated with multiple sclerosis -- Full text
- 2021 Apr 14 Experimental infection with the hookworm, Necator americanus, is associated with stable gut microbial diversity in human volunteers with relapsing multiple sclerosis -- Full text | PDF
- 2021 Jul The fatty acid-binding protein (FABP) decreases the clinical signs and modulates immune responses in a mouse model of experimental autoimmune encephalomyelitis (EAE) -- Full text
- 2021 Jan 29 The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy -- Full text
- 2020 Dec Dicrocoelium ova can block the induction phase of experimental autoimmune encephalomyelitis -- Full text (preprint version Mars 16)
- Dicrocoelium eggs have a great potential to stimulate immunomodulation towards treatment of EAE during the initial phase.
- 2020 Sept 29 The Helminth Parasite Heligmosomoides polygyrus Attenuates EAE in an IL-4Rα-Dependent Manner -- Full text | PDF
- 2020 Aug 28 An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination -- Full text
- ✅ 2020 Jun 15 Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial -- Full text.
- This research was also reported in Science Daily, where it was noted that, “The findings of the research… show that infecting MS patients with a safe dose of… Necator americanus induces immunoregulatory responses and boosts the number of cells which help keep the immune system under control.” [1]
- In fact, the trial data reveal that more than half the patients given hookworms did not develop any new lesions, and the conclusion of the trial's lead researcher was that, "there would be a niche for this approach - for individuals with mild disease who don't want to take immunomodulating drugs for life and would prefer a more natural approach.” [2]
- The conclusion published by this study's authors in their formal report - that NA appeared to be ineffective against MS - and the sceptical tenor of the editorial from Jama Neurology, [3] were based on the fact that the particular statistical endpoint determined for the trial by its designers - the cumulative number of new/enlarging T2 and new enhancing T1 lesions at month 9 - had not been reached. This conclusion is a glaring example of the endemic failure within the mainstream medical research community to understand, and accommodate, the unique requirements of living organisms when they are being trialled as a therapy. To read more about this, see, Problems with clinical trials using live helminths.
- 2020 Jan-Feb Perspectives of People with Multiple Sclerosis About Helminth Immunotherapy -- Full text
- 2019 Jul-Dec The endosymbiotic role of intestinal helminths in multiple sclerosis: Promising probiotic hypothesis -- Full text
- 2019 Apr 23 Helminths products directly modulate T cells that mediate experimental autoimmune encephalomyelitis
- 2018 Oct 17 Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease -- Full text
- 2017 Oct 3 The Effects of Intestinal Nematode L4 Stage on Mouse Experimental Autoimmune Encephalomyelitis
- 2017 Oct 1 Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: Results of the HINT 2 clinical trial -- PDF
- 2017 Sep Human herpes virus antibody levels in helminth treated and placebo controlled multiple sclerosis patients | [5] (thesis)
- 2017 Jun 28 Helminth Products Potently Modulate Experimental Autoimmune Encephalomyelitis by Downregulating Neuroinflammation and Promoting a Suppressive Microenvironment -- Full text | PDF)
- 2017 Jun 13 Environmental factors influencing multiple sclerosis in Latin America -- Full text | PDF
- 2017 Mar Trichuris suis secrete products that reduce disease severity in a multiple sclerosis model (TSO)
- 2017 Jan 17 Helminth-induced Ly6Chi monocyte-derived alternatively activated macrophages suppress experimental autoimmune encephalomyelitis -- Full text | PDF
- 2017 Jan 15 Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System -- Full text
- 2016 Nov 24 A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis -- Full text | PDF
- 2016 May 25 Intestinal Parasites and Immunomodulation in Neuroinflammatory Disease (chapter of Neuro-Immuno-Gastroenterology)
- 2016 Jan 21 Policy and regulations in light of the human body as a ‘superorganism’ containing multiple, intertwined symbiotic relationships | PDF
- 2016 Sept 1 Acute Strongyloides venezuelensis infection did not prevent EAE development: implications for hygiene hypothesis -- PDF
- This study used a treatment period of only 12 weeks, which is inadequate when assessing the efficacy of helminths, and it also used a novel TSO formulation with a pH of 5, when it is known that storage of TSO above pH4 may impede its therapeutic effect in humans. [6] The conclusions drawn by the authors of this study about the efficacy of TSO are therefore not reliable.
- 2015 Jul 25 Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis -- Full text | PDF (TSO)
- ✅ 2015 Apr 18 Overcoming Evolutionary Mismatch by Self-Treatment with Helminths: Current Practices and Experience. (Full text PDF)
- This socio-medical study revealed that the human hookworm, Necator americanus (NA), is extremely effective as a treatment for MS, with a success rate of approximately 50% for the progressive forms of the disease (PPMS and SPMS), and more than 90% for the relapsing-remitting form (RRMS).
- 2014 Dec 4 Helminth Therapy for MS (multiple sclerosis)
- 2014 Nov Helminth therapy or elimination: epidemiological, immunological, and clinical considerations
- 2014 Oct 15 Effects of soluble helminth components on human monocytes and macrophages in neuroinflammation.
- 2014 Apr 29 - TSO PH5 - HINT 2 - Clinical Trial of Helminth-induced Immunomodulatory Therapy (HINT 2) in Relapsing-Remitting Multiple Sclerosis (P3.149) (TSO).
- This trial employed a novel TSO formulation with a pH of 5, when it is known that storage of TSO at a pH above 4 may impede its therapeutic effect in humans. [7] The conclusions drawn by the authors of this study about the efficacy of TSO are therefore not reliable.
- (NB the phase 1 (HINT1 with TSO PH 2.3 was successfull: Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study -- Full text | PDF)
- 2014 Regulatory B cells, helminths, and multiple sclerosis -- Full text (Part of the book series: Methods in Molecular Biology)
- 2013 Dec 19 Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy -- Full text | PDF (TSO)
- 2013 Oct 1 Parasite infections in multiple sclerosis modulate immune responses through a retinoic acid-dependent pathway -- Full text | PDF
- 2013 Jun Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis -- Full text
- 2013 April 25 Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial -- Full text PDF (TSO)
- 2013 Mar Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis -- Full text
- 2013 Mar Helminth therapy and multiple sclerosis -- Full text
- 2012 Sept Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients (TSO in Secondary Progressive Multiple Sclerosis (SPMS))
- 2012 Aug 24 Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients? Full text | PDF
- 2012 Mar Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis -- Full text | [8]
- 2012 Jan Neuroprotective potential beyond immunoregulation of helminth infection as a therapeutic target in multiple sclerosis -- Full text
- 2011 Jun Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study -- Full text | PDF (TSO).
- Treatment: Five subjects with newly diagnosed, treatment-naive relapsing-remitting multiple sclerosis (RRMS) were given 2500 TSO orally every 2 weeks for 3 months in a baseline versus treatment control exploratory trial.
- Results: The mean number of new gadolinium-enhancing magnetic resonance imaging (MRI) lesions (n-Gd+) fell from 6.6 at baseline to 2.0 at the end of TSO administration
- (NB HINT2 [9], [10] was done with a version of TSO at pH 5.0, which is known to be less effective than the TSO product at pH 2.4 that is commercially available and was used in Weinstock's early trials.)
- 2011 Apr Helminths and multiple sclerosis: will old friends give us new treatments for MS? (No abstract)
- 2011 May Experimental autoimmune encephalomyelitis evolution was not modified by multiple infections with Strongyloides venezuelensis -- Full text
- The Taenia crassiceps-induced immune regulation decreased experimental autoimmune encephalomyelitis severity by dampening T cell activation, proliferation and migration to the CNS.
- 2010 Oct Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response -- Full text
- 2010 Jun Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats -- Full text
- 2009 Nov 1 Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms -- Full text | PDF
- Proposal for the first Phase 2 trial using a controlled number of Necator americanus in the treatment of Multiple Sclerosis. (Also reported by Science Daily [11] and the Mail Online. [12]) (NA)
- 2008 Apr Trichinella spiralis: modulation of experimental autoimmune encephalomyelitis in DA rats -- Full text
- 2007 Dec Resistance to experimental autoimmune encephalomyelitis development in Lewis rats from a conventional animal facility -- Full text
- Also reported by Science Daily [13] and the BBC. [14]).
- In 2007, Correale and Farez demonstrated that patients with multiple sclerosis who were accidentally colonised by one or more of a variety of helminth species experienced a reduced number of disease exacerbations compared with patients who were helminth-free. This was the first study to explore the effect of helminth colonisation on immune response and the natural course of Relapsing Remitting Multiple Sclerosis. It showed that RRMS progressed much more slowly in patients who hosted intestinal worms.
- 2007 Jul Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis -- Full text
- 2006 Dec 12 Multiple sclerosis and the hygiene hypothesis
- 2003 Sept Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis -- Full text | PDF
- 2003 Jan Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization -- Full text | PDF
- 2002 Jun 3 Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections -- Full text
Ongoing research projects:
- 2023-2026 - Leveraging helminth infection to limit neuroinflammation in MS (Dr. Lisa Osborne, University of British Columbia)
For more research on helminths and MS, use the search function on your device (Control+F on a PC, Command+F on a Mac or 'Find in page' in the drop-down menu from the three dots icon on a mobile) to search the following page for references to “multiple sclerosis” (rather than “MS”).
Comments by researchers[edit | edit source]

For more comments by researchers about helminthic therapy in general, see the following list.
The anecdotal evidence[edit | edit source]
- Three annual reports by the same person:
- Two reports by a different individual, written nine months apart.
- The following reports were posted by yet another person, nearly three years apart.
- "It has been 3 years since my last relapse. And since I've had hookworms, all left over traces from my last relapse have disappeared completely… I think that the hookworms have stopped any disease activity and that has allowed my brain time to heal… I'm incredibly happy and relieved with the results, and I encourage anyone with MS to get treated with helminths, the sooner the better.” (Link expired)
- “I've been on HT for almost 4 years now, and I still have not had a relapse or any new or active lesions on my yearly MRI's.” (Link expired)
- "I followed Swank/Jelinek's diet when I was diagnosed eight years ago (2003) and I believe the diet made a huge difference for me but the hookworms stopped my ms progression 100%" (Reported to a closed group, Sept 2011)
- "I realized - after a few comments from friends - that I had stopped craving ADD drugs like Vyvanse and Adderall for their sheer energizing effect, stopped drinking – ready for this? – a pot and a half of coffee a day. I had more energy than I have had in something like 15 years. The afternoon fatigue wasn’t there as strongly – still there but reduced in its ability to floor me. I didn’t wake up tired and ready to go back to bed… All in all, I'm a happy girl so far. To have some energy back - not complete but so, so much better - is beyond joyful." (Reported by an MS patient, 4 months after inoculation, in a private discussion, Dec 2011.)
- "… had 3rd top up last week and since then almost symptom free - just slight nerve fatigue towards end of the day." (Reported in a private discussion, Feb 2012)
- "… while my M.S. hasn't disappeared, I've been consistently stronger with no long weak periods, no more daily or every other day elevated temperature leading to falling and exhaustion, and I'm starting to remember what feeling "normal" feels like..." (Link expired)
- "Two months after I took the hookworms, all my MS symptoms vanished. I have not had a relapse or any kind of MS activity since I started hookworm therapy. Every brain MRI that I have had (4 of them) has shown no active lesions and no new lesions. In fact, a few lesions have actually disappeared… As far as I am concerned, hookworm therapy has been a total success so far, and I recommend it to anyone with MS." (Link expired)
- "I am on Necator Americanus starting in September 2007. I reached complete remission in six months. I'm happy to report my MS is still in remission!" (Reported to a closed group, Nov 2012)
- The following two reports are by the same blogger, two years apart.
- “… my MS has pretty much been benign since my initial diagnosis almost 5 years ago; I have still had what I call “ghost symptoms” from time to time. These are not real relapses. They happen when I get overheated or have a fever. The body mimics MS symptoms like tingling in the feet or hands and extreme fatigue. Since my wormies moved in, I’ve experienced none of these. I have been able to be out in the heat of the summer without problems. In a lot of ways, the last 6 months have been absolutely fantastic!” [16]
- "My MS has been pretty much non-existent. So much so that some days I can almost forget about it… When I take a step back to analyze where I am health wise now as opposed to where I was 2 or more years ago, the results truly have been life changing." [17]
- "18 months so far. Nothing to report! All symptoms have disappeared late summer of 2011 and since it's all quiet. Is there anything else to add?" (Reported to a closed group, Jan 2013)
- "My most recent MRI… showed no new disease activity over the last year. Yay! Over the last two years I have made numerous life changes including beginning a disease modifying therapy, helminthic therapy, a transition to a pesco-vegetarian diet, stress reduction techniques, and regular exercise. My doctor is telling me to keep doing the same stuff, including the helminthic therapy." (Reported Mar 2013, two years after diagnosis, following inoculations with a total of 135 hookworm larvae.)
- ☹️ "Since I'm not having the desired effect for my MS from the 230 HW I've been hosting for more than two years, and the 1500 WW I've been hosting for about a year, I'm considering terminating them and trying TSO for a while." (Link expired)
- "Have been inoculated with hookworms since Sept of 2011. Dietary changes were made years ago and I now have been off any MS medication for over 2 months and am feeling and doing very well." (Reported to a closed group, July 2013)
- "Since my second "dose" I can now lift my left leg which I couldn't do before. I actually can walk around without my cane at times. In fact, the other day I was walking around my daughter-in-law's home and my grandson tells me "Grandma, you aren't using your cane". I didn't even realize that I wasn't using it. I can feel that this therapy is working and I am slowly getting stronger. I now feel like I have hope for a better future with being able to function better." (Reported in a private message, July 2013)
- “The more important results were my M.S. results which I have responded very well to. I have not had any symptoms since one month after inoculation…now I do not need MS meds or anything.. They are truly a miracle for me..” (Link expired)
- “Coming up to 3 year anniversary of starting Helminthic therapy. Overall things very good. No significant relapses. Holding down very well paid job and loving it.” (Posted to a closed group, Jan 2014)
- The following reports are all from one individual who was diagnosed in 2012 and has hosted NA since 2013.
- “Had my MRI results this week (after 3 inoculations with NA) and compared them to 2 years ago. My brain lesions have disappeared… I am taking no MS meds, just Paleo diet and 20,000 ius Vitamin D daily. My gait has improved and neurologist tested it this week. I am full of energy and back in full time work.” [18]
- “All the MRI’s this year (2018) showed no active lesions and no new brain lesions. I have had lots of energy, I am working and even took up Tango! I dance 💃🏻 for hours in 3 inch stilettos 👠!” [19] [20]
- “After 7 years of only Helminthic Therapy, I am (still) in remission from MS!!!” [21]
- "Got my results for my 10th year MRI’s. The results from the brain, cervical and thoracic images with and without contrast show no new or active lesions once more! Feeling grateful for my helminth population!!! I have only inoculated with hookworms in all these years. I have had no antibiotics, nor steroids, nor medicine!!! I love my old friends!" [22]
- ☹️ "Unfortunately, I am not a success story with helminthic therapy. I was diagnosed 20 years ago with RRMS, but my condition has since progressed to SPMS. I had hookworms for about three years. It completely cured my allergies, but my multiple sclerosis did not improve. During the three years, I experimented with many different doses of hookworm and found that my MS symptoms were continuing to progress slowly. In 2012 or 2013, I got a severe stomach bug and had the worst MS attack of my life. After that, I stopped trying HT and continued back onto disease modifying medication." (Via private message.)
- “What a difference a year and 12 hookworms can make! Yesterday I went snowboarding!!!! Woo!!! Last time I tried that was 13 months ago, and it didn't go well. But yesterday went great! Nerve pain in my feet has diminished so I could wear boots. My fatigue and depression have eased. Had no vertigo. I could control my legs and my eyes were rock solid steady. I could wear contact lenses (first time in 1.5 years.) And I could even breathe.” (Link expired)
- “I have very mild MS. I saw total remission with hookworms about 8 years ago, and haven’t had a serious exacerbation since.” [23]
- “I have had MS for 10 years, and NA for 3 years without any issues. Prior to NA, relapses came every 6-8 months. Now, since the NA, I have not had a relapse. That’s 3 years with greatly reduced symptoms, including pain. I cannot encourage people enough to get on board with this alternative to standard medicine. It can be in addition to your current treatment too.” (Link expired)
- "I have been on HDC for MS for 6 months. I started slowly on 30 HDC every 2 weeks and stayed on this for a few months. I have good weeks and bad weeks with symptoms which relate to the phases in my monthly cycle, and I found my bad weeks were better than I would expect. After developing a new symptom, I stopped the HDC for 6-8 weeks to see if this was causing it. It wasn’t, and I noticed I was worse in the bad phases of my cycle, so I restarted the HDC. Before that, I had got up to 50 HDC every 2 weeks, and I resumed at that dose for a month. Then I increased it to 100 HDC every 2 weeks. I don’t think I’ve found my optimal dose yet, but there is definitely a positive effect happening for me and, yesterday, my osteopath commented on how well I was walking." (Edited from this post.)
- "My sister in law has MS and RA, and she’s been in remission since getting on NA with a small amount of TSO." [24]
- "I have RRMS. I was in a clinical trial years ago and took TSO. I started with 5 brain lesions and 10 months later had 0. I felt great I was so pleased… Since then I have taken no meds. My MS has only shown one new lesion a few years ago." [25]
Reporting your own experience
To report your personal experience of using helminthic therapy to treat MS, please use our bespoke reporting tool.
Best helminth species to treat MS[edit | edit source]
In 2015, Cheng et al, reported that:

This study found a couple of individuals who had used HDC to treat MS. One of them reported a 40% success rate using HDC alone, while the other reported 100% success by combining HDC with NA. Seven NA users with RRMS all reported a 100% success rate, as did someone who combined TSO with NA.
The MS personal stories reported in this wiki are almost exclusively from NA hosts (see, Helminthic therapy personal stories: MS), so NA is clearly the go-to species for MS. For details of how to use NA, see Self-treating with NA.
Further reading[edit | edit source]
Given that helminthic therapy can take a while to begin producing benefits (up to 2 years in the case of NA [26]), it can help to have alternative treatment options to turn to while waiting for the worms to begin to work. The following document contains a wide range of alternative, mostly science-based, natural approaches.